Welcome
-
Home
-
Register
-
Login
-
Help/FAQ
-
0 items
Search
Enter keywords, a title or
a report id number below.
In All Categories
---------------------
Telecom & Computing
Business & Finance
Mfg & Construction
Pharma & Healthcare
Consumer & Retail
Gov & Public Sector
Energy & Transport
Country Reports
Company Reports
---------------------
Transcripts
Advanced
Select a currency for use throughout the site
Australia Dollars
Canada Dollars
Euro
Japan Yen
Sweden Kroner
Switzerland Francs
UK Pounds
US Dollars
Viewing report
Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
|
More
Electronic
Obesity Drug Discovery: Success and Challenges for a New Pharmaceutical Market
Decision Resources, Inc., June 2005, Pages: 18
Description
Table of Contents
Companies Mentioned
Enquire before Buying
Send to a Friend
- Company
- Alizyme
- Amgen (from Tularik acquisition)
- Amylin Pharmaceuticals
- Arena Pharmaceuticals
- Merck
- Metabolic Pharmaceuticals
- Nastech Pharmaceuticals
- Peptimmune
- Regeneron
- Sanofi-Aventis
- Solvay/Bristol-Myers Squibb
Customers who bought this item also bought
Obesity Drug Pipeline: Developing Therapies for a Complex Disease
Obesity Drug Discoveries: What The Future Holds + Obesity Tracker
Obesity Drug Discoveries: What the Future Holds
Anti-Obesity Drugs - Global Strategic Business Report
Anti-Obesity Drugs - Trends & Opportunities Worldwide
Obesity - The $11 billion market that never was
Metabolic Diseases Pipeline Analysis:Focus on Dyslipidemia, Diabetes, and Obesity
Obesity Drug Markets in the US and EU: Analysis of Product Pipelines and the Competitive Environment
Clinical Management of Obesity (Technical Insights)
Booming Global Obesity Drug Market
Obesity Opinion Leader Forum, 2002
Obesity - Behavioral, Medical, and Surgical Management, 2nd Edition (2009 Update)
Top of page
All rights reserved. © Copyright 2009 Research and Markets
0
Terms and conditions
Privacy Policy
Publishers
Employment Opportunities
Site Map
Link to us
Webmaster
